Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000757381 | SCV000885582 | uncertain significance | not provided | 2017-08-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000757381 | SCV001875111 | uncertain significance | not provided | 2021-07-26 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Labcorp Genetics |
RCV000757381 | SCV002129722 | uncertain significance | not provided | 2022-04-15 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1524 of the HSPG2 protein (p.Ala1524Val). This variant is present in population databases (rs144546505, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with HSPG2-related conditions. ClinVar contains an entry for this variant (Variation ID: 618683). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV000757381 | SCV003809280 | uncertain significance | not provided | 2020-04-02 | criteria provided, single submitter | clinical testing |